Effect of onset of type 2 diabetes on risks of cardiovascular disease and heart failure among new Zealanders with impaired glucose tolerance over 25 years: tapered-matched landmark analysis - Cardiovascular Diabetology

  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 92 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 40%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

An analysis published in Cardiovascular Diabetology finds that the diagnosis of type 2 diabetes mediates the risk of cardiovascular disease and heart failure among New Zealanders with impaired glucose tolerance.

Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011 July 02;378:31–40.

Barr ELM, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the australian diabetes, obesity, and Lifestyle Study . Circulation 2007 July 10;116:151–7.

Cai X, Liu X, Sun L, He Y, Zheng S, Zhang Y et al. Prediabetes and the risk of heart failure: a meta-analysis. Diabetes Obes Metab 2021 August 01;23:1746–53. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011 March 03;364:829–41.

Robinson T, Simmons D, Scott D, Howard E, Pickering K, Cutfield R, et al. Ethnic differences in type 2 diabetes care and outcomes in Auckland: a multiethnic community in New Zealand. N Z Med J 2006 June. 1997;02:U.Dafni U. Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes 2011 May 01;4:363–71.

Yu D, Zhao Z, Simmons D. Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study. Cardiovasc Diabetol 2020 October 10;19:174–020. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004 October 25;164:2147–55.

Eriksson KF, Lindgarde F. Prevention of type 2 diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991 December 01;34:891–8. Eriksson KF, Lindgarde F. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise. Diabetologia 1998 September 01;41:1010–6.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 22. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Why Honda seriously risks losing Rins to a MotoGP rivalAlex Rins could leave the Honda fold and join a MotoGP rival as the Spaniard has grown frustrated at its treatment of him this season Full story ⬇️
Source: autosport - 🏆 90. / 53 Read more »